Speakers

Dr. Eric Pang serves as a senior chemist in the Office of Generic Drugs. He specializes in the analysis of peptide and large molecule drugs. Currently, he serves as the SME for peptide drug products, develops product-specific guidances of complex drug products, responds to controlled correspondences, pre-ANDA meeting requests, citizen petitions, and consultations. He is also managing several regulatory science projects related to generic peptide products and topics related to immunogenicity. Dr. Pang has over 10 years of experience in the Agency as a research chemist, a CMC reviewer, and a policy lead. Dr. Pang received his Ph.D. in Biochemistry from UCLA, and undergraduate degrees in Molecular Cell Biology and Legal Studies from UC Berkeley.